Explore/

Minimally Invasive Surgery

Minimally Invasive Surgery

2.21k followers19 symbols Watchlist by Motif Investing

Global adoption of minimally invasive procedures could spark new growth. The global minimally invasive surgery market is forecast to reach $35.5 billion by the end of 2016 with compound annual growth rate ("CAGR") of 8.2%.

19 Symbols

To view complete list, get the Yahoo Finance App

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • TheStreet.com14 hours ago

    Medtronic Expected to Earn $1.24 a Share

    is expected to report earnings of $1.24 a share on sales of $7.5 billion before the market opens Feb. 19, based on a FactSet survey of 26 analysts. The stock has fallen 1% since the company last reported earnings on Nov. 20. Quarterly estimates have fallen less than 1 cent a share in the past month.

  • Endologix (ELGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Zacks20 hours ago

    Endologix (ELGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    Endologix (ELGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Will Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Earnings Grow Over The Next Few Years?
    Simply Wall St.21 hours ago

    Will Intuitive Surgical, Inc.’s (NASDAQ:ISRG) Earnings Grow Over The Next Few Years?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! The latest earnings announcement Intuitive Surgical, Inc. (NASDAQ:ISRG) released inRead More...

  • Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4
    Zacks22 hours ago

    Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4

    Cryolife (CRY) revenues increase year over year across all geographies and major segments.

  • The Subtle Signal That the Bull Market Could Soon End
    Motley Fool2 days ago

    The Subtle Signal That the Bull Market Could Soon End

    The current bull market is near the end of its 10th year. But this indicator could mean that it's near the end -- period.

  • Investing.com2 days ago

    Economic Calendar - Top 5 Things to Watch This Week

    Investing.com - Markets will be keeping abreast of the next round of trade discussions between the U.S. and China in Washington this week, as the two sides race to reach a deal that would avert a tariff increase on Chinese goods by March 1.

  • CNBC3 days ago

    Cramer's game plan: Investors shouldn't underestimate the importance of a trade deal with China

    CNBC's Jim Cramer eyes the week ahead, which will feature earnings reports from Walmart, CVS and more. "If we get a [trade] deal ... I think the stocks of many international companies ... can rally because at this point the earnings estimates are too low," Cramer says. Norwegian Cruise "could be the standout that potentially reignites the whole group, which is dirt cheap," the "Mad Money" host says.

  • Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock
    Zacks4 days ago

    Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock

    Cardiovascular Systems (CSII) has been firing on all cylinders of late to expand its geographical presence. The company is progressing well with its objective to introduce OAS globally.

  • Quidel (QDEL) Q4 Earnings and Revenues Surpass Estimates
    Zacks4 days ago

    Quidel (QDEL) Q4 Earnings and Revenues Surpass Estimates

    Quidel's (QDEL) flagship Triage sees strong growth in China in Q4.

  • Stanley Druckenmiller's Top 6 Buys for the 4th Quarter
    GuruFocus.com4 days ago

    Stanley Druckenmiller's Top 6 Buys for the 4th Quarter

    Former George Soros partner releases portfolio

  • Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down
    Zacks5 days ago

    Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down

    In recent times, Quest Diagnostics (DGX) is facing several reimbursement issues which have hurt revenues.

  • Globus Medical (GMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks5 days ago

    Globus Medical (GMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • BSX is Breaking Out for the First Time Since September 2018
    InvestorPlace5 days ago

    BSX is Breaking Out for the First Time Since September 2018

    To receive further updates on this Boston Scientific (NYSE:BSX) trade as well as an alert when it's time to take profits, sign up for a risk-free trial of Strategic Trader today.We are opening a new bullish trade on Boston Scientific (NYSE:BSX). BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson's deep brain stimulation systems and more.Medical device companies, like BSX, have been steady performers on Wall Street since 2013 as an increasing number of Americans have gained insurance coverage and are now able to receive treatment for their health conditions.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Strong Earnings and New AcquisitionsBSX released its quarterly earnings numbers last week on Feb. 6, before market open, and thrilled investors by announcing revenue numbers that were in-line with expectations and by beating earnings expectations by $0.07 per share -- coming in at $2.56 billion and $0.27 per share, respectively.Medical device companies have been able to maintain their pricing power in negotiations with insurance companies. This is a trend that is likely to continue well into the future, so BSX could see strong revenue and earnings for years to come.BSX is also expanding the medical devices it manufactures, which could result in more sales. In November 2018, it announced it would acquire BTG plc., the surgical device manufacturer. BSX also just acquired Millipede, Inc., a company that developed technology for dealing with mitral regurgitation. Breaking Above $38The company's positive earnings announcement seems to have been the catalyst investors had been waiting for to break the stock out of the consolidation range it had been in since September 2018. The post-earnings breakout at $38 completed and confirmed a "broadening-wedge" bullish continuation pattern for the stock.Daily Chart of Boston Scientific (BSX) -- Chart Source: TradingViewWhereas it had served as resistance before earnings, we anticipate $38 is now going to serve as a strong support level moving forward. If it does, we can sell slightly out-of-the-money puts on the stock and keep our entire premium when they expire. That would give us the chance to roll out our puts and collect even more income.To find out which BSX puts we're selling -- and to get access to our full portfolio of income-generating trades -- consider signing up for risk-free trial subscription to Strategic Trader today. InvestorPlace advisers John Jagerson and S. Wade Hansen, both Chartered Market Technician (CMT) designees, are co-founders of LearningMarkets.com, as well as the co-editors of Strategic Trader.Follow our Facebook page to receive each Trade of the Day direct to your News Feed -- and join the conversation.Compare Brokers The post BSX is Breaking Out for the First Time Since September 2018 appeared first on InvestorPlace.

  • Baxter's Acute Therapies Profile Strong, Competition Rife
    Zacks5 days ago

    Baxter's Acute Therapies Profile Strong, Competition Rife

    Expanding product portfolio and strong presence in the international markets are key positives for Baxter (BAX) at the moment.

  • Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines
    Zacks5 days ago

    Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines

    Bio-Techne (TECH) sees increase in revenues across key segments.

  • Did Johnson & Johnson Just Spit in Alphabet's Face?
    Motley Fool5 days ago

    Did Johnson & Johnson Just Spit in Alphabet's Face?

    J&J's latest acquisition might appear to threaten its partnership with Alphabet to develop robotic surgical systems. But another player could be impacted even more.

  • Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings
    Zacks5 days ago

    Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings

    Medtronic (MDT) is expected to maintain a decent market share in the core pacing backed by the continued uptake of Micra Transcatheter Pacing System in Q3.

  • Here's Why Investors Should Buy CONMED (CNMD) Stock Now
    Zacks5 days ago

    Here's Why Investors Should Buy CONMED (CNMD) Stock Now

    CONMED's (CNMD) guidance for 2019 buoys optimism in the stock.

  • DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates
    Zacks5 days ago

    DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates

    DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.

  • Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
    Zacks5 days ago

    Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

    Medtronic (MDT) closed at $90.67 in the latest trading session, marking a +0.47% move from the prior day.

  • Here Is What's Surprising About J&J's Robotic Surgery Buyout
    Investor's Business Daily6 days ago

    Here Is What's Surprising About J&J's Robotic Surgery Buyout

    Dow Jones component Johnson & Johnson on Wednesday announced it plans to pay $3.4 billion to acquire robotic surgery player Auris Health. Auris Health is a rival to Intuitive Surgical.

  • 10 ‘Buy-and-Hold’ Stocks to Own Forever
    InvestorPlace6 days ago

    10 ‘Buy-and-Hold’ Stocks to Own Forever

    [Editor's note: This story was previously published in July 2018. It has since been updated and republished.]Investing to "buy and hold" is trickier than it looks. The increasing pace of technological change means even the most successful, dominant companies have to continually adapt to keep up. Industries like energy, real estate and even consumer products are facing potentially significant long-term changes going forward. In any era, amassing a collection of retirement stocks simply by buying the best companies and holding them for years can be a risky endeavor.General Motors (NYSE:GM) was a classic "widows and orphans" stock until last decade when GM wound up going bankrupt. United States Steel (NYSE:X) once was a pillar of corporate America and a buy-and-hold stock. GM shares basically haven't moved in a quarter of a century. Polaroid and Eastman Kodak (NYSE:KODK) were once blue-chip stocks. Both went bankrupt as cameras changed from film to digital.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut there still are stocks to buy and hold out there that can last forever, while offering dividend income along the way. * 9 U.S. Stocks That Are Coming to Life Again Here are 10 such retirement stocks to hold forever.Source: Shutterstock Bank of America (BAC)Dividend Yield: 2.7%It might seem strange to open the list with Bank of America (NYSE:BAC). After all, we're less than a decade on from the financial crisis. During that crisis, BofA acquisition Countrywide Financial blew up in spectacular fashion, after pioneering many of the risky tactics that led to the bubble and subsequent bust.But this is a different BofA.Net consumer charge-offs hit a decade-long low in the company's second quarter. Performance on credit metrics continues to improve across the portfolio. The Merrill Lynch unit is posting record margins. Government regulations have been criticized as slowing growth -- but they've undoubtedly lowered risk as well, even if observers might argue that a better balance is needed.No less than Warren Buffett is now BofA's largest shareholder, through his Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B). And the Oracle of Omaha is fond of saying that his favorite holding period is "forever."That seems likely true for BAC stock as well.Source: Mustafa Khayat Via Flickr Diageo (DEO)Dividend Yield: 1.75%Change has come to the alcohol industry, with the number of breweries exploding worldwide and new distilleries popping up as well. The brands owned by Diageo (NYSE:DEO) are well-positioned to adapt to shifting tastes.Diageo owns classic brands like Johnnie Walker whisky, Tanqueray gin, Smirnoff vodka, and Harp and Guinness beer, among many others. What most have in common is a timeless quality and worldwide brand recognition. As a result, while beverage giants like Coca-Cola (NYSE:KO) and Anheuser Busch InBev (NYSE:BUD) have struggled with earnings growth, Diageo grew net income by 13.5% in fiscal 2018 and expects consistent growth going forward. * Buy These 5 Stocks to Play the Megatrend of the Century Yet at a sub-20x forward multiple, and with a dividend yield approaching 2%, Diageo stock isn't all that dearly valued. Long-term investors would do well to own DEO and perhaps use the dividends to buy a bottle or two of fine whisky.Source: U.S. Embassy Kyiv Ukraine via Flickr (Modified) Medtronic (MDT)Dividend Yield: 2.21%In this day and age, the U.S. healthcare market in particular seems potentially volatile. Concerns about increased spending and political battles over the Affordable Care Act create more questions than answers.But even with that uncertainty, Medtronic (NYSE:MDT) isn't going anywhere. The company's devices are an integral part of modern medicine, ranging from pacemakers to stents to bone grafts to imaging systems.Even the risks involved in the sector look priced into MDT. Medtronic's days of double-digit annual growth may well be behind it, but it's not finished increasing earnings or dividends. MDT stock likely isn't finished rising, either.Source: Shutterstock NextEra Energy (NEE)Dividend Yield: 2.42%Utility stocks are among the most common safe, buy-and-hold stocks. NextEra Energy (NYSE:NEE) is now the largest electric utility in the U.S. by market capitalization. That might actually be the only problem with NEE stock.NextEra shares gained 7.6% year-to-date, and trades just off record highs. Potential valuation concerns aside, NextEra looks like a winner. It serves customers in the southern Florida region, still one of the nation's fastest-growing areas. A 21x forward P/E multiple is high for the space but not outlandishly so. And a 2.7% dividend yield provides income along the way. * 10 Best Dividend Stocks to Buy for the Next 10 Months Investors looking for value in the space might look for a smaller play like cheaper Dominion Energy (NYSE:D). But it's usually worth paying for quality, and NextEra Energy looks like one of the best utility stocks out there.Source: Blue Genie via FlickrDividend Yield: 1.7%McCormick & Company (NYSE:MKC) is another quality company whose valuation might spook some investors. But MKC stock very rarely is offered cheap; if it gets below $122, you should consider buying and holding this stock.The company's market leadership in spices and seasonings provides both an impressive moat and protection against economic downturns. MKC stock did dip after the company acquired French's mustard and Frank's RedHot sauce from Reckitt Benckiser (OTCMKTS:RBGLY) at a price that looked a bit high to many investors. But MKC has recovered those gains and then some.Top-line growth for McCormick likely isn't going to be explosive, but it will be steady. The same has been true of MKC stock, which has returned an average of 13% a year over the past decade, including dividends.With continuous cost-cutting initiatives, the contribution from the acquired brands and organic growth (and growth in organic products), MKC still should be able to provide double-digit annual returns going forward as well.Source: Shutterstock Dividend Yield: 2.13%Allstate Corp (NYSE:ALL) long has used the tagline, "You're in good hands," and it's true for Allstate investors as well. ALL stock has almost quadrupled from late-2011 lows. And there could be more upside to come.After all, Allstate isn't particularly expensive, trading at a 15.9 P/E. * The 9 Best Stocks to Invest In During a Manic Market Once any short-term worries subside, ALL should resume its march upward.Source: Shutterstock International Flavors & Fragrances (IFF)Dividend Yield: 1.99%International Flavors & Fragrances (NYSE:IFF) is a company most consumers encounter every day without knowing it and many investors aren't exactly hip to it, either.As its name suggests, the company develops flavors & fragrances across 13 categories, including cosmetics, perfumes, beverages and sweet flavors. Sales and earnings have increased consistently and so has IFF's share price. At a26.79 P/E, IFF does look a bit pricey. But, as with McCormick and other stocks on this list, investors should pay for quality.IFF's hidden, but key role, in so many industries, gives it a great deal of protection against both competition and macro factors. Acquisitions and a growing cosmetic additive business both provide room for growth.Consumers may not know IFF, but investors should.Source: Shutterstock Dividend Yield: 1.15%Lamb Weston (NYSE:LW) was spun off from Conagra Brands (NYSE:CAG) last year. Lamb Weston is the No. 1 potato producer in the United States. In fact, it manufactures the well-known fries at McDonald's (NYSE:MCD), among other restaurant chains.Lamb Weston also has a consumer business (including a small segment that manufactures frozen vegetables), while serving restaurants of all sizes. Health concerns might seem a long-term headwind against the business, but growth has been steady for years, and margins continue to improve.LW is targeting international markets for growth, as French fries have much more limited penetration, while international audiences generally are intrigued by Americanized products.Despite growth and leading market share, LW stock isn't particularly cheap, trading at about 21x next year's earnings. The company did pick up a fair amount of debt in the CAG spinoff. But it's paying that debt down, which should lower interest expense and boost cash flow going forward. * 7 Stocks With Too Much Riding On China With many similar stocks trading at much higher multiples, LW seems to have room for upside. And international growth should offset any health-related concerns in the U.S., should they arise. America's love affair with French fries isn't going to suddenly end, and that should ensure years of stability for Lamb Weston at least.Source: Shutterstock Fortune Brands (FBHS)Dividend Yield: 1.86%Investors are commonly advised to diversify their portfolio. Fortune Brands Home & Security (NYSE:FBHS) has done just that. The company operates in four segments: Cabinets, Plumbing, Doors, and Security. Among its well-known brands are Moen in plumbing, and MasterLock in security.FBHS is more of a cyclical stock than most on this list, and the company no doubt has benefited from the steady, if slow, housing recovery in the U.S. But the company's products also generate relatively stable replacement demand, and a 1.86% dividend yield provides modest, but growing, income.Fortune Brands has been an impressive company since its founding and a solid stock since its 2011 IPO. There may be a bit more volatility here, but that's a worthwhile price to pay for long-term investors. There's enough value in Fortune Brands to ride out any market jitters.Source: Shutterstock Dividend Yield: 1.94%Republic Services (NYSE:RSG) is a bit smaller and likely a lot less well-known than rival Waste Management (NYSE:WM). But in this case, that's not necessarily a bad thing.Republic Services has outgrown its larger competitor in both sales and earnings over the past five years. RSG stock has modestly outperformed WM over the same period as well. Investors appear to believe that will continue, as Republic Services is valued a bit higher than Waste Management, at least based on forward earnings multiples.Both RSG and WM are solid long-term plays. Contracted revenue and steady demand should support both companies for years to come. There's room for further acquisitions in a relatively fragmented space. Republic Services gets the nod here due to slightly better growth and more room for margin improvement. * 7 High-Dividend Stocks Yielding More Than 5% (Plus a Bonus) But investors looking for safe, stable growth can't go wrong with either RSG or WM.As of this writing, Vince Martin was long MKC.Compare Brokers The post 10 'Buy-and-Hold' Stocks to Own Forever appeared first on InvestorPlace.

  • Johnson & Johnson to pay $3.4B to buy Auris Health
    American City Business Journals6 days ago

    Johnson & Johnson to pay $3.4B to buy Auris Health

    The Redwood City company's robotic camera helps doctors see inside the body, including in the lungs. It was recently valued at about $2.1 billion after raising $220 million in funding in November.

  • NuVasive (NUVA) Earnings Expected to Grow: Should You Buy?
    Zacks6 days ago

    NuVasive (NUVA) Earnings Expected to Grow: Should You Buy?

    NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates
    Zacks7 days ago

    STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates

    STERIS (STE) continues to gain from strength in all business segments in Q3.